Meeting
2017 ASCO Annual Meeting
Stereotactic body radiation therapy to generate comparable survival to surgery in treating hepatocellular carcinoma (HCC): Results of 756 patients.
Authors
Feng Ming Kong
Indiana University Department of Radiation Oncology, Indianapolis, IN
Feng Ming Kong , Yong Zang , Wenhu Pi , David Long , Susannah Ellsworth , Naoyuki Saito , Marwan Ghabril , Marco A Lacerda , David M Agarwal , Bert O’Neil , Mark Tann , Richard C. Zellars , Mary A. Maluccio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4080)
DOI
10.1200/JCO.2017.35.15_suppl.4080
Abstract #
4080
Poster Bd #
72
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.
First Author: Michael Yan
Poster
2022 ASCO Annual Meeting
A phase II study of stereotactic body radiotherapy (SBRT) combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma (HCC).
First Author: Yixing Chen
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2020 ASCO Virtual Scientific Program
SBRT versus nephrectomy in the treatment of renal cell carcinoma.
First Author: Mausam Patel